ESSA Pharma Inc (EPIX)
5.94
-0.30
(-4.81%)
USD |
NASDAQ |
May 21, 10:34
ESSA Pharma Cash and Short Term Investments (Quarterly): 135.89M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 135.89M |
December 31, 2023 | 142.12M |
September 30, 2023 | 148.08M |
June 30, 2023 | 152.47M |
March 31, 2023 | 157.04M |
December 31, 2022 | 163.07M |
September 30, 2022 | 167.24M |
June 30, 2022 | 174.60M |
March 31, 2022 | 181.02M |
December 31, 2021 | 189.20M |
September 30, 2021 | 194.93M |
June 30, 2021 | 202.26M |
March 31, 2021 | 208.60M |
December 31, 2020 | 74.50M |
September 30, 2020 | 78.33M |
June 30, 2020 | 36.48M |
March 31, 2020 | 39.91M |
December 31, 2019 | 45.93M |
September 30, 2019 | 53.32M |
June 30, 2019 | 4.874M |
Date | Value |
---|---|
March 31, 2019 | 8.598M |
December 31, 2018 | 12.17M |
September 30, 2018 | 14.83M |
June 30, 2018 | 18.06M |
March 31, 2018 | 21.69M |
December 31, 2017 | 1.868M |
September 30, 2017 | 3.957M |
June 30, 2017 | 7.330M |
March 31, 2017 | 12.62M |
December 31, 2016 | 10.86M |
September 30, 2016 | 8.985M |
June 30, 2016 | 12.38M |
March 31, 2016 | 15.93M |
December 31, 2015 | 2.609M |
September 30, 2015 | 1.579M |
June 30, 2015 | 6.235M |
March 31, 2015 | 10.44M |
December 31, 2014 | 3.446M |
September 30, 2014 | 3.70M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
4.874M
Minimum
Jun 2019
208.60M
Maximum
Mar 2021
127.49M
Average
150.27M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Acasti Pharma Inc | 25.11M |
Aurinia Pharmaceuticals Inc | 350.49M |
Edesa Biotech Inc | 2.800M |
Lexaria Bioscience Corp | 4.793M |
Xenon Pharmaceuticals Inc | 699.60M |